EDITORIAL
Published on 09 Aug 2022
Editorial: Cytokine Release Syndrome in COVID-19: Mechanisms and Management
doi 10.3389/fphar.2022.965714
- 981 views
- Frontiers in Pharmacology
- Inflammation Pharmacology
- Research Topics
- Cytokine release syndrome in COVID-19: mechanisms and management
Cytokine release syndrome in COVID-19: mechanisms and management
6,774
Total Downloads
28k
Total Views and Downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 22 Jun 2022
Profiling Differential Effects of 5 Selective Serotonin Reuptake Inhibitors on TLRs-Dependent and -Independent IL-6 Production in Immune Cells Identifies Fluoxetine as Preferred Anti-Inflammatory Drug Candidate
doi 10.3389/fphar.2022.874375
- 3,039 views
- 10 citations
ORIGINAL RESEARCH
Published on 07 Mar 2022
17α-Hydroxyprogesterone Caproate Inhibits Cytokine Production via Suppression of NF-κB Activation
doi 10.3389/fphar.2022.831315
- 1,490 views
- 1 citation
REVIEW
Published on 14 Feb 2022
Increased Circulating Cytokines Have a Role in COVID-19 Severity and Death With a More Pronounced Effect in Males: A Systematic Review and Meta-Analysis
doi 10.3389/fphar.2022.802228
- 3,950 views
- 36 citations
REVIEW
Published on 12 Jan 2022
The Role of Interleukin-8 in Lung Inflammation and Injury: Implications for the Management of COVID-19 and Hyperinflammatory Acute Respiratory Distress Syndrome
doi 10.3389/fphar.2021.808797
- 15,158 views
- 85 citations
Published in
Frontiers in Pharmacology
- Inflammation Pharmacology
Participating Journals
Frontiers in Immunology
Inflammation PharmacologyOffline
- 5.7 impact factor
- 9.8 citescore
Impact
- 28kTopic views
- 21kArticle views
- 6,774Article downloads